Sanders calls on FDA to allow low-cost rivals to $375k Catalyst drugUS Senator Bernie Sanders says the FDA should allow pharmacies and generic manufacturers to make low-cost copies of Share XSanders calls on FDA to allow low-cost rivals to $375k Catalyst drughttps://pharmaphorum.com/news/sanders-calls-on-fda-to-allow-low-cost-rivals-to-375k-catalyst-drug/
Marathon halts launch of Duchenne drug after price outcryCompany says it will listen to concerns of patient advocates Share XMarathon halts launch of Duchenne drug after price outcryhttps://pharmaphorum.com/news/marathon-halts-launch-duchenne-drug-price-outcry/